Glaxo seeks OK to expand breast cancer drug use

(AP) -- GlaxoSmithKline PLC on Wednesday applied for approval in the U.S. and Europe to sell an existing breast-cancer drug as a first-line treatment.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news157815399.html">Glaxo seeks OK to expand breast cancer drug use</a></p> <p>(AP) -- GlaxoSmithKline PLC on Wednesday applied for approval in the U.S. and Europe to sell an existing breast-cancer drug as a first-line treatment.</p>